课题基金 / 基金详情

项目摘要

项目成果

Galit Alter的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Core B (Immunology Core) will provide standardized humoral immune monitoring assay services for evaluating antibody responses elicited by Ad26-Env/Gag/Pol prime, Env gp140 protein boost (Ad26/Env) vaccine regimens in the studies described in this IPCAVD program. Core B leadership will work closely with investigators responsible for the studies described in Project 1 and Project 2 and will participate actively in the scientific mission of the overall IPCAVD program. The primary goal of Core B is to provide the leadership and the technical expertise to ensure that all vaccine-induced humoral responses will be profiled in a standardized fashion and that the IPCAVD leadership is kept abreast of the latest developments in assessing vaccine-induced neutralizing and non-neutralizing humoral immunity, particularly in relation to their ability to prevent viral infection. To accomplish these goals, we propose the following three Specific Aims: Specific Aim 1. To perform standardized neutralizing antibody (NAb) assays in both NHP and humans Specific Aim 2. To perform standardized non-neutralizing antibody assays in both NHP and humans Specific Aim 3. To integrate all antibody data into a Systems Serology profiling approach to define correlates of protective immunity
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SARS-CoV-2 Variant Testing
  • 批准号:
    10446500
  • 项目类别:
  • 资助金额:
    $34.82万
  • 财政年份:
    2021
  • 负责人:
    Galit Alter
  • 依托单位:
Systems Serology Core
  • 批准号:
    10616544
  • 项目类别:
  • 资助金额:
    $29.45万
  • 财政年份:
    2021
  • 负责人:
    Galit Alter
  • 依托单位:
Systems Serology Core
  • 批准号:
    10203487
  • 项目类别:
  • 资助金额:
    $39.61万
  • 财政年份:
    2021
  • 负责人:
    Galit Alter
  • 依托单位:
Systems Serology Core
  • 批准号:
    10449292
  • 项目类别:
  • 资助金额:
    $40.74万
  • 财政年份:
    2021
  • 负责人:
    Galit Alter
  • 依托单位:
海外基金